Physician

Luis Alberto Dehesa, M.D.

According to 2025 Medicare claims, Luis Dehesa, M.D. (NPI: 1629412259) practices dermatology in the Fresno, CA market, with the plurality of this provider's patient population coming from Madera, CA. This provider's primary affiliated billing organization is EDGAR S. MACIAS, M.D., INC (NPI: 1871882712; TIN: 274988308) and primary practice location at 93720-0361.

Dehesa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,017 traditional Medicare patients, billed 7,039 HCPCS/CPT codes, and received $655,541 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,823 prescription claims across 688 beneficiaries totaling $3,515,051 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 21 records totaling $70,041. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $70,367 to $655,541. Similarly, Part D prescription costs have moved sharply higher in recent years, from $37,223 to $3,515,051. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$345K$691K2016 Medicare payment: $70,367 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $311,989 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $490,616 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $570,520 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $531,157 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $511,690 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $641,081 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $690,755 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $655,541 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
20163641,014$70,367
20177534,489$311,989
20188936,377$490,616
20199126,981$570,520
20208196,131$531,157
20219356,154$511,690
20229206,244$641,081
20231,0116,777$690,755
20241,0177,039$655,541

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.8M$3.5M2015 Drug cost: $37,223 (USD; Tot_Drug_Cst)2016 Drug cost: $65,578 (USD; Tot_Drug_Cst)2017 Drug cost: $442,539 (USD; Tot_Drug_Cst)2018 Drug cost: $1,142,293 (USD; Tot_Drug_Cst)2019 Drug cost: $1,489,864 (USD; Tot_Drug_Cst)2020 Drug cost: $2,134,814 (USD; Tot_Drug_Cst)2021 Drug cost: $2,403,572 (USD; Tot_Drug_Cst)2022 Drug cost: $3,186,652 (USD; Tot_Drug_Cst)2023 Drug cost: $3,405,830 (USD; Tot_Drug_Cst)2024 Drug cost: $3,515,051 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201548157$37,223
2016176395$65,578
20173771,245$442,539
20185031,722$1,142,293
20195322,088$1,489,864
20205672,736$2,134,814
20216152,688$2,403,572
20225692,365$3,186,652
20235942,398$3,405,830
20246882,823$3,515,051

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more224302$92
11102Biopsy of related skin growth, first growth330441$71
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more611973$61
17000Destruction of precancer skin growth, 1 growth373560$40
17003Destruction of precancer skin growth, 2-14 growths3202,108$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa514,004$1,024,285
Humira(Cf) PenAdalimumab411,148$384,981
TremfyaGuselkumab241,344$308,006
Cosentyx Sensoready (2 Pens)Secukinumab35980$283,734
StelaraUstekinumab131,104$278,390

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.9$472Janssen Scientific Affairs, LLC
Research PaymentsReported research-related payment or transfer-of-value amount.12$69,569Janssen Research & Development, LLC
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Luis Alberto Dehesa, M.D.?

Tedicare shows public-source Medicare data for Luis Alberto Dehesa, M.D. (NPI 1629412259), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Luis Alberto Dehesa, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Luis Alberto Dehesa, M.D.?

Luis Alberto Dehesa, M.D. is linked to EDGAR S. MACIAS, M.D., INC (billing NPI 1871882712) in the available physician profile data.

Does Luis Alberto Dehesa, M.D. have Open Payments data?

Luis Alberto Dehesa, M.D. has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.